Isgec Heavy Engineering Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
ISGEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Isgec Heavy Engineering reported Q1 FY26 results with standalone revenue from operations at ₹98,380 lakhs, down ~19% YoY from ₹1,21,540 lakhs in Q1 FY25. Standalone profit after tax was ₹8,659 lakhs (vs ₹8,850 lakhs YoY), with EPS of ₹11.78 (vs ₹12.04). On a consolidated basis, revenue declined ~12.8% YoY to ₹1,34,099 lakhs, and profit from continuing operations fell ~33% YoY to ₹6,394 lakhs; including discontinued operations, total PAT was ₹5,863 lakhs. The auditor (SCV & Co. LLP) issued an unmodified limited review report on both sets of results. The Board recommended a dividend of ₹5 per equity share (face value ₹1) for FY25, subject to shareholder approval at the AGM on September 16, 2025 (record date September 8, 2025). Key ongoing matter: sale of the Singapore step-down subsidiary (Bioeq Energy Holding One, Cayman Islands) for USD 10 million, now delayed and expected by September 15, 2025; total loan and interest receivables tied to this transaction stand at USD 102.35 million (~₹87,775 lakhs). Board committees were also reconstituted.
Revenue contraction in both standalone and consolidated results may weigh on near-term sentiment, though standalone profitability was largely protected. The pending divestment of the Philippines ethanol business and continued delays in the Bioeq sale introduce some execution risk. The ₹5/share dividend offers near-term shareholder return.